Physician profile

Brian J Morrison

Cardiovascular Disease · Medford, OR

NPI 1407864028

$209.17

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$43.15

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $43.76 2022-2023 Resonate El Icd Vr
Cardinal Health 200 LLC $42.29 2019
Janssen Pharmaceuticals, INC $31.55 2019-2020
Covidien LP $22.69 2019
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $21.80 2023 Lifevest
Kci USA, INC. $17.00 2019
Biom'Up Sa $16.22 2019
Opsens INC. $13.86 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brian J Morrison

$209.17

in general payments reported 2019-2025

Years
2019-2023
Top company
Boston Scientific Corporation

https://glasscript.com/doctor/291130/brian-j-morrison

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.